作者：
Karlan,B.Y. [1]
;
Oza,A.M. [2]
;
Richardson,G.E. [3]
;
Provencher,D.M. [4]
;
Hansen,V.L. [5]
;
Buck,M. [6]
;
Chambers,S.K. [7]
;
Ghatage,P. [8]
;
PippittJr.,C.H. [9]
;
BrownIII,J.V. [10]
;
Covens,A. [11]
;
Nagarkar,R.V. [12]
;
Davy,M. [13]
;
LeathIII,C.A. [14]
;
Nguyen,H. [15]
;
Stepan,D.E. [16]
;
Weinreich,D.M. [17]
;
Tassoudji,M. [18]
;
Sun,Y.-N. ;
Vergote,I.B.
作者单位：
Northern Utah Associates, Ogden, UT, United States
[1]
Sir Charles Gairdner Hospital, Perth, WA, Australia
[2]
Princess Margaret Hospital, Canada
[3]
Toronto-Sunnybrook Regional Cancer Centre, Toronto, ON, Canada
[4]
University Hospital Leuven, Leuven, Belgium
[5]
Piedmont Hematology Oncology Associates, Winston-Salem, NC, United States
[6]
Gynecologic Oncology Associates, Newport Beach, CA, United States
[7]
Tom Baker Cancer Centre, Calgary, AB, Canada
[8]
Amgen, South San Francisco, CA, United States
[9]
Amgen, Thousand Oaks, CA, United States
[10]
Royal Adelaide Hospital, Adelaide, SA, Australia
[11]
Division of Gynecologic Oncology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, United States
[12]
Arizona Cancer Center, Tucson, AZ, United States
[13]
Sheridan Healthcare Corporation, Hollywood, FL, United States
[14]
BrookeArmyMedical Center, FortSam Houston, TX, United States
[15]
Centre Hospitalier de l'Université de Montréal-H?pital Notre-Dame, Montreal, QC, Canada
[16]
Cabrini Hospital, Melbourne, VIC, Canada
[17]
Curie Manavata Cancer Centre, Nashik, Maharashtra, India
[18]
发布时间
2013-11-20
换一批
